Polimorfismo do gene CYP2D6 1846 G/A em associação com o Acidente Vascular Encefálico/Aneurisma em uma população do Distrito Federal (Brasil)
Keywords:
Stroke, genetic polymorphism, Cytochrome P-450 CYP2D6, Hypertencion, Diabetes MellitusAbstract
Objective: To investigate a possible association of the CYP2D6 1846 G/A gene in HS/aneurysm patients residing in the Federal District (Brazil), as well as to crosscheck the information obtained with clinical manifestations and prognosis. Method: The investigation was a population-based case-control study involving 81 cases with HS/aneurysm. The samples genotyping employed the PCR-RFLP technique with a significance level of 5%. Results: The attempt to associate genotypic and allelic frequencies to the HVA/Aneurysm resulted in no statistical difference. Nevertheless, in patients with the GG genotype and hypertension, the risk for HS increased 44 times. Participants with GG genotype also had statistically higher glycemia mean levels in the case group. Conclusion: The presence of the CYP2D6 1846 G/A polymorphism should be extensively, as it is necessary to clarify whether such polymorphisms represent associations with HS and Intracerebral Aneurysm.
References
Medeiros C, Fernandes S, Lopes J, Cacho E, Cacho R. Effects of mirror therapy through functional activites and motor standards in motor function of the upper limb after stroke. Fisioter e Pesqui. 2014;21(3):264–70.
Wajngarten M, Silva GS. Ischaemic Heart Disease , Stroke and Risk Factors Hypertension and Stroke : Update on Treatment Ischaemic Heart Disease , Stroke and Risk Factors. Radcliffe Cardiol. 2019;14(2):111–5.
Montaner J, Mendioroz M, Delgado P, García-Berrocoso T, Giralt D, Merino C, et al. Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: The S100B/RAGE pathway. J Proteomics [Internet]. 2012;75(15):4758–65. Available from: http://dx.doi.org/10.1016/j.jprot.2012.01.033
Mota DVN, Meireles ALF de, Viana MT, Almeida R de C de A. Mirror therapy for upper limb rehabilitation in chronic patients after stroke. Fisioter em Mov. 2016;29(2):287–93.
Kumar A, Aakriti, Gupta V. A review on animal models of stroke: An update. Brain Res Bull [Internet]. 2016;122:35–44. Available from: http://dx.doi.org/10.1016/j.brainresbull.2016.02.016
Silva MV DA. Aspectos clínicos e epidemiológicos dos casos de acidente vascular encefálico hemorrágico intraparenquimatoso: perfil epidemiológico em uma série monocêntrica no Distrito Federal. 2013.
Hopewell JC, Clarke R. Emerging Risk Factors for Stroke: What Have We Learned from Mendelian Randomization Studies? Stroke. 2016;47(6):1673–8.
Bezerra LS, Santos-Veloso MAO, Bezerra Junior NDS, Fonseca LC Da, Sales WLA. Impacts of Cytochrome P450 2D6 (CYP2D6) Genetic Polymorphism in Tamoxifen Therapy for Breast Cancer. Rev Bras Ginecol e Obstet. 2018;40(12):794–9.
Yasukochi Y, Satta Y. Molecular evolution of the CYP2D subfamily in primates: Purifying selection on substrate recognition sites without the frequent or long-tract gene conversion. Genome Biol Evol. 2015;7(4):1053–67.
De Leon J, Armstrong SC, Cozza KL. Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19. Psychosomatics. 2006;47(1):75–85.
Nepomnyashchikh DL, Vavilin VA, Aidagulova S V., Makarova SI, Karavaeva Y, Shchepotina EG, et al. Cytochrome P450 2D6 polymorphism is a molecular genetic marker of liver cirrhosis progression. Bull Exp Biol Med. 2012;152(5):633–6.
da Silva JK, dos Anjos KF, Santos VC, Boery RNS de O, Santa Rosa D de O, Boery EN. Intervenções para cuidadores de sobreviventes de acidente vascular cerebral: revisão sistemática. Rev Panam Salud Pública. 2018;42(4):1–9.
Gu L, Wu G, Long J, Su L, Yan Y, Chen Q, et al. The role of TNF-α 308G>A polymorphism in the risk for ischemic stroke. Am J Med Sci. 2013;345(3):227–33.
Hernández FL. Estudio de las bases genéticas de la diabetes tipo 2: Identificación de variantes de baja frecuencia mediante secuenciación masiva. Universidad politécnica de Calencia. 2019.
Lu Y, Qin X, Li S, Zhang X, He Y, Peng Q, et al. Quantitative assessment of CYP2D6 polymorphisms and risk of Alzheimer’s disease: A meta-analysis. J Neurol Sci. 2014;343(1–2):15–22.
Ramos JM. Análise De Equilíbrio E Funcionalidade Em Indivíduos Hemiparéticos Pós-Ave. Ciências Biológicas e Saúde Unit [Internet]. 2018;5(1):103–16. Available from: http://www.scielo.br/pdf/eins/v16n1/pt_1679-4508-eins-S1679-45082018AO4247.pdf
Sandrim VC, Tanus-Santos JE. O conhecimento em farmacogenômica pode auxiliar no controle da pressão arterial em pacientes com hipertensão de difícil controle ? J Hypertens. 2008;15(1):34–6.
Ali AAA, Wassim NM, Dowaidar MM, Yaseen AE. Genetic polymorphism of CYP2D6 gene among Egyptian hypertensive cases. J Basic Appl Zool [Internet]. 2013;66(4):228–33. Available from: http://dx.doi.org/10.1016/j.jobaz.2012.12.002
Semiz S, Dujic T, Ostanek B, Prnjavorac B, Bego T, Malenica M, et al. Analysis of CYP2C9*2, CYP2C19*2, and CYP2D6*4 polymorphisms in patients with type 2 diabetes mellitus. Bosn J Basic Med Sci. 2010;10(4):287–91.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Revista de Divulgação Científica Sena Aires
This work is licensed under a Creative Commons Attribution 4.0 International License.
-
Atribuição — Você deve dar o crédito apropriado, prover um link para a licença e indicar se mudanças foram feitas. Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso.
- Sem restrições adicionais — Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.
